IRCT20150929024266N6招募中2 期
Evaluating the rate of complete clinical response following total neoadjuvant therapy by using chemoradiotherapy by Intensity modulated radiation therapy with simultaneous integrated boost (IMRT-SIB) in patients with lower rectal cancer; a Phase II randomized clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Non-metastatic rectal cancer (>T2N0) that is less than 5 cm from the anal wedge
排除标准
- •Inability to do MRI (whether mechanical or claustrophobia)
- •Lack of proper MRI for disease staging
- •Multiple comorbidities
- •Inadequate blood, kidney, or liver indices for the possibility of receiving chemotherapy
- •History of previous malignancies in the pelvis or other areas of the intestine, history of previous surgeries or radiotherapy in the pelvic area
- •MSI-H patients who are candidates for immunotherapy
- •History of IBD or FAP and other colon polyposis syndromes
- •Active malignancies in other areas of the body.
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CR-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialEUCTR2005-005139-84-ATPIERRE FABRE MEDICAMENT200
进行中（未招募）
不适用
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CT-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialocally advanced non small cell lung cancerEUCTR2005-005139-84-CZPIERRE FABRE MEDICAMENT200
进行中（未招募）
1 期
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CT-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialocally advanced non small cell lung cancerMedDRA version: 8.1Level: LLTClassification code 10025044Term: Lung cancerEUCTR2005-005139-84-FIPIERRE FABRE MEDICAMENT200
进行中（未招募）
1 期
DRelapsing Remitting Multiple SclerosisMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-000708-26-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE50
招募中
3 期
The effect of chemotherapy in rectal cancerRectal cancer.Malignant neoplasm of rectumIRCT20200803048281N1Tehran University of Medical Sciences70